These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6337102)

  • 1. Monoclonal antibodies to Trypanosoma cruzi inhibit motility and nucleic acid synthesis of culture forms.
    Alves MJ; Aikawa M; Nussenzweig RS
    Infect Immun; 1983 Jan; 39(1):377-82. PubMed ID: 6337102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies against the flagellar fraction of epimastigotes of Trypanosoma cruzi: complement-mediated lytic activity against trypomastigotes and passive immunoprotection in mice.
    Segura EL; Bua J; Rosenstein de Campanini A; Subias E; Esteva M; Moreno M; Ruiz AM
    Immunol Lett; 1986 Oct; 13(4):165-71. PubMed ID: 3095228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies mediating viable immunofluorescence and protection against Trypanosoma cruzi infection.
    Heath AW; Martins MS; Hudson L
    Trop Med Parasitol; 1990 Dec; 41(4):425-8. PubMed ID: 2127473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies against the flagellar fraction of epimastigotes of Trypanosoma cruzi: immunoprotection against metacyclic trypomastigotes obtained by immunization of mice with an affinity-purified antigen.
    Ruiz AM; Esteva M; Subias E; Moreno M; Rosenstein de Campanini A; Velazquez E; Segura EL
    Mol Biochem Parasitol; 1990 Feb; 39(1):117-25. PubMed ID: 2106075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trypanosoma cruzi: cellular and antibody response against the parasite in mice immunized with a 19-amino acid synthetic peptide.
    Búa J; Bontempi EJ; Levin M; Orn A; Velasco D; Moreno M; Levi-Yeyati P; Engstrom A; Segura EL; Ruiz AM
    Exp Parasitol; 1991 Jan; 72(1):54-62. PubMed ID: 1993465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies to metacyclic stage antigens of Trypanosoma cruzi.
    Chao D; Dusanic DG
    Am J Trop Med Hyg; 1985 Jul; 34(4):694-701. PubMed ID: 3927760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Passive transfer of a monoclonal antibody specific for a sialic acid-dependent epitope on the surface of Trypanosoma cruzi trypomastigotes reduces infection in mice.
    Franchin G; Pereira-Chioccola VL; Schenkman S; Rodrigues MM
    Infect Immun; 1997 Jul; 65(7):2548-54. PubMed ID: 9199418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification of metacyclic trypomastigotes of Trypanosoma cruzi and Trypanosoma dionisii from culture using an epimastigote-specific monoclonal antibody.
    Petry K; Schottelius J; Baltz T
    Parasitol Res; 1987; 73(3):224-7. PubMed ID: 3295861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of trypomastigotes' infectivity by a monoclonal antibody directed to a glycoconjugated fraction of epimastigotes of Trypanosoma cruzi.
    Imaz MS; Esteva M; Velázquez E; Ruiz AM; Segura EL; Marcipar AJ
    Rev Latinoam Microbiol; 1997; 39(1-2):33-46. PubMed ID: 10932713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryptic epitope explains the failure of a monoclonal antibody to bind to certain isolates of Trypanosoma cruzi.
    Kirchhoff LV; Hieny S; Shiver GM; Snary D; Sher A
    J Immunol; 1984 Nov; 133(5):2731-5. PubMed ID: 6207242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibodies to stages of Trypanosoma cruzi: characterization and use for antigen detection.
    Araujo FG; Sharma SD; Tsai V; Cox P; Remington JS
    Infect Immun; 1982 Jul; 37(1):344-9. PubMed ID: 6809632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphism of the 35- and 50-kilodalton surface glycoconjugates of Trypanosoma cruzi metacyclic trypomastigotes.
    Mortara RA; da Silva S; Araguth MF; Blanco SA; Yoshida N
    Infect Immun; 1992 Nov; 60(11):4673-8. PubMed ID: 1328061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial inhibition of trypomastigote entry into cultured mammalian cells by monoclonal antibodies against a surface glycoprotein of Trypanosoma cruzi.
    Alves MJ; Abuin G; Kuwajima VY; Colli W
    Mol Biochem Parasitol; 1986 Oct; 21(1):75-82. PubMed ID: 3534565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mexican Trypanosoma cruzi isolates: in vitro susceptibility of epimastigotes to anti-trypanosoma cruzi drugs and metacyclic forms to complement-mediated lysis.
    León-Pérez F; Gómez-Garcia L; Alejandre-Aguilar R; López R; Monteón VM
    Vector Borne Zoonotic Dis; 2007; 7(3):330-6. PubMed ID: 17760512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of antibody and resistance to lysis of trypomastigotes of Trypanosoma cruzi.
    Jacobson KC; Fletcher RC; Kuhn RE
    Parasite Immunol; 1992 Jan; 14(1):1-12. PubMed ID: 1557225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of monoclonal antibodies against the trypomastigote stage of Trypanosoma cruzi by use of iminobiotinylated surface polypeptides.
    Beard CA; Wrightsman RA; Manning JE
    Mol Biochem Parasitol; 1985 Aug; 16(2):199-212. PubMed ID: 3929088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of monoclonal antibodies for the identification of a strain of Trypanosoma cruzi.
    Bongertz V; Pontes de Carvalho LC
    Am J Trop Med Hyg; 1992 Apr; 46(4):435-9. PubMed ID: 1575290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenic differentiation of Trypanosoma cruzi and Trypanosoma rangeli by means of monoclonal-hybridoma antibodies.
    Anthony RL; Cody TS; Constantine NT
    Am J Trop Med Hyg; 1981 Nov; 30(6):1192-7. PubMed ID: 7034561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane-bound antibodies to bloodstream Trypanosoma cruzi in mice: strain differences in susceptibility to complement-mediated lysis.
    Krettli AU; Weisz-Carrington P; Nussenzweig RS
    Clin Exp Immunol; 1979 Sep; 37(3):416-23. PubMed ID: 116784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of resistance to lysis by the alternative complement pathway in Trypanosoma cruzi trypomastigotes: effect of specific monoclonal antibody.
    Schenkman S; Güther ML; Yoshida N
    J Immunol; 1986 Sep; 137(5):1623-8. PubMed ID: 2943798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.